CIGNA has agreed to end its relationship with the Ingenix database and pay $10 million towards the development of a new database, according to a news release from the N.Y. Office of the Attorney General.
ASC Coding, Billing & Collections
As "out of pocket" expenses continue to climb for patients, providers must do everything they can to make it easier for patients to pay their bills. Those medical facilities that succeed will reap the benefits of improved cash flow and…
N.Y. Attorney General Andrew Cuomo announced a settlement with the nation’s largest health insurer, Indianapolis-based Wellpoint over allegations that the insurer manipulated reimbursement rates, according to news releases.
Medicare has tentatively decided that it will not cover virtual colonscopies, citing inadequate evidence that it is an effective test for colorectal cancer, according to an announcement on the CMS Web site and a report in the New York Times.
The number of uninsured Americans will rise from 45 million in 2009 to 54 million in 2019, according to Senate testimony by Congressional Budget Office Director Douglas Elmendorf.
Medical device maker NeuroMetrix has agreed to pay $3.7 million to settle federal allegations that it gave kickbacks to physicians, according to news releases from the U.S. Attorney's Office and NeuroMetrix.
The American Medical Association (AMA), along with several state medical associations, have filed two separate class-action lawsuits against Aetna Health and CIGNA Corp. alleging that the companies underpaid physicians using flawed billing practices, according to an AMA news release.
Highmark and Independence Blue Cross in Pennsylvania have dropped their merger proposal, withdrawing their applications to the Pennsylvania Insurance Department.
Q: When coding neoplasms, I have always waited to receive the pathology report to report a diagnosis on the UB-04. I was taught to wait because the proper diagnosis of the neoplasm and the size of the specimen is needed…
Here are 96 questions in 23 categories you should address when considering and reviewing managed care contracts.
